París-Coderch, Laia http://orcid.org/0000-0003-2145-5752
Soriano, Aroa http://orcid.org/0000-0001-9659-1471
Jiménez, Carlos http://orcid.org/0000-0001-9219-3492
Erazo, Tatiana
Muñoz-Guardiola, Pau
Masanas, Marc
Antonelli, Roberta
Boloix, Ariadna http://orcid.org/0000-0002-1648-5589
Alfón, José
Pérez-Montoyo, Héctor
Yeste-Velasco, Marc
Domènech, Carles
Roma, Josep http://orcid.org/0000-0001-7692-6123
Sánchez de Toledo, Josep
Moreno, Lucas
Lizcano, José M. http://orcid.org/0000-0002-3154-5383
Gallego, Soledad http://orcid.org/0000-0002-4712-9624
Segura, Miguel F. http://orcid.org/0000-0003-0916-3618
Funding for this research was provided by:
Ministerio de Economía y Competitividad (FPU16/01099, FPU16/01099, FJCI_2015_24212)
Ministry of Economy and Competitiveness | Agencia Estatal de Investigación (FJCI_2015_24212, INNPACTO/IPT-2012-0614-010000 and SAF2015-64237-R)
Generalitat de Catalunya (2017FI_B_00095)
Article History
Received: 12 June 2020
Revised: 26 August 2020
Accepted: 27 August 2020
First Online: 17 September 2020
Conflict of interest
: P.M., H.P.M., M.Y.V., J.A. and C.D. are Ability Pharmaceuticals employees; C.D. holds shares of the company; J.M.L., M.F.S. and S.G. are advisory members of Ability Pharmaceuticals. The remaining authors declare that they have no conflict of interest.